To ensure compliance with the EC Grant Agreement and Consortium Agreement, and to ensure that the projects agreed deliverables and milestones are achieved within budget, and on time. To this end, strict procedures have been installed and officialised in a Project Management Manual. Procedures entail production and dissemination of project documentation, meetings, achievement of milestones and deliverables and the budget
To ensure the effective inter-WP alignment of activities and promote efficient and effective internal communication and decision-making
To develop a feasible business plan for the sustainable continuation of the operational infrastructures and processes needed to continue the VALUE-Dx activities well beyond the projects 4-years, and to widen the applicability of study findings beyond the current priority of CA-ARTI in community care settings
https://www.value-dx.eu/wp-content/uploads/2024/04/Untitled-3.png9951488Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-04-22 11:33:552024-04-22 14:55:43PRUDENCE and ADEQUATE-paediatric studies: the final steps
Meet Dr. Füsun Can, a medical doctor and professor in Istanbul. She leads a multidisciplinary team focused on antibiotic resistance research. With expertise in virology and a commitment to collaborative efforts, Dr. Can’s work extends beyond the laboratory, aiming to address emerging infectious disease challenges across Turkey.
https://www.value-dx.eu/wp-content/uploads/2024/04/Picture-Fusun-scaled.jpg24542560Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-04-15 15:05:072024-04-16 13:50:39AMR expert interview with Dr. Füsun Can
https://www.value-dx.eu/wp-content/uploads/2023/08/shutterstock_1714915966-scaled.jpg14212560Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-02-02 12:34:072024-04-22 12:34:30VALUE-Dx paper on barriers and facilitators in pricing and funding policies of European countries impacting the use of point-of-care diagnostics for acute respiratory tract infections